AN2 Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
1800 El Camino Real, Suite D, Menlo Park, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/13/2024, 04:06 PM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report AMENDMENT NO. 1 Aug 28, 2024
SC 13G/A Report Aug 14, 2024
SC 13G/A Report SC 13G/A Aug 13, 2024
SC 13G Report Aug 12, 2024
SC 13G Report Jul 3, 2024
SC 13G Report SC 13G Apr 10, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report SC 13G A AN2 Feb 14, 2024
SC 13G Report SC 13G Feb 13, 2024
SC 13G/A Report JHG PLC AND JHBIF OWN <5% Feb 12, 2024
SC 13G/A Report SC 13G/A Feb 9, 2024
SC 13G/A Report SC 13G/A Feb 9, 2024
SC 13G Report SC 13G Jul 25, 2023
SC 13G Report BIOTECH (NON-RIC) OWNS 5% Jul 5, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report AMENDMENT NO. 1 TO THE SCHEDULE 13G Feb 14, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G Report SC 13G Feb 13, 2023
SC 13G Report SC 13G AN2 THERAPEUTICS Feb 13, 2023
SC 13G Report SC 13G Feb 10, 2023
SC 13G Report AN2 THERAPEUTICS, INC. Apr 8, 2022
SC 13G Report AN2 THERAPEUTICS, INC. Apr 8, 2022
SC 13G Report THE SCHEDULE 13G Apr 4, 2022